LIR Life Sciences Corp.
SKNY
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 01/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 678.80K | 763.30K | 1.90K | -- | |
| Total Receivables | 36.20K | 15.30K | 8.80K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 52.20K | 7.40K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 767.20K | 785.90K | 10.70K | -- | |
|
|
|||||
| Total Current Assets | 767.20K | 785.90K | 10.70K | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 74.70K | 73.20K | 75.10K | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 841.90K | 859.20K | 85.90K | -- | |
|
|
|||||
| Total Accounts Payable | 57.60K | 367.30K | 271.20K | -- | |
| Total Accrued Expenses | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | 25.30K | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 57.60K | 367.30K | 296.50K | -- | |
|
|
|||||
| Total Current Liabilities | 57.60K | 367.30K | 296.50K | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | 25.30K | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 57.60K | 367.30K | 296.50K | -- | |
|
|
|||||
| Common Stock & APIC | 2.42M | 1.05M | 216.70K | -- | |
| Retained Earnings | -2.18M | -561.90K | -427.40K | -- | |
| Treasury Stock & Other | 536.00K | -- | -- | -- | |
| Total Common Equity | 784.40K | 491.90K | -210.70K | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 784.40K | 491.90K | -210.70K | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 784.40K | 491.90K | -210.70K | -- | |
|
|
|||||